HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 207 filers reported holding HORIZON PHARMA PLC in Q2 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $7,293,000 | +42.0% | 275,940 | +5.0% | 0.02% | +25.0% |
Q4 2018 | $5,137,000 | +3.7% | 262,873 | +3.9% | 0.01% | +20.0% |
Q3 2018 | $4,953,000 | +18.2% | 252,984 | -0.0% | 0.01% | +11.1% |
Q2 2018 | $4,191,000 | +18.7% | 253,073 | +1.8% | 0.01% | +12.5% |
Q1 2018 | $3,531,000 | -6.0% | 248,690 | -3.4% | 0.01% | 0.0% |
Q4 2017 | $3,758,000 | +13.4% | 257,408 | -1.5% | 0.01% | +14.3% |
Q3 2017 | $3,314,000 | -3.5% | 261,389 | -9.6% | 0.01% | 0.0% |
Q2 2017 | $3,434,000 | -26.9% | 289,277 | -9.0% | 0.01% | -22.2% |
Q1 2017 | $4,696,000 | -12.8% | 317,733 | -4.5% | 0.01% | -18.2% |
Q4 2016 | $5,384,000 | -13.1% | 332,733 | -2.7% | 0.01% | -15.4% |
Q3 2016 | $6,197,000 | +11.0% | 341,833 | +0.9% | 0.01% | +8.3% |
Q2 2016 | $5,581,000 | +80.4% | 338,833 | +184.4% | 0.01% | +71.4% |
Q1 2015 | $3,094,000 | +99.1% | 119,131 | -1.2% | 0.01% | +75.0% |
Q4 2014 | $1,554,000 | +5.4% | 120,531 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $1,474,000 | – | 120,018 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |